期刊文献+

塞来昔布通过PI3K/Akt通路调控胃癌细胞凋亡 被引量:3

COX-2 Regulation of Apoptosis in Human Gastric Cancer Cells via the PI3K/Akt Signaling Pathway
在线阅读 下载PDF
导出
摘要 目的:探讨塞来昔布通过PI3K/Akt信号通路调控胃癌细胞凋亡的机制。方法:塞来昔布体外处理人胃癌细胞株SGC-7901后,透射电镜观察细胞超微结构的改变,实时荧光定量RT-PCR法和Western Blot法检测蛋白激酶B(Akt)、天冬氨酸特异性半胱氨酸蛋白酶-8(Caspase-8)、Caspase-9的表达。结果:塞来昔布处理细胞后,透射电镜下观察到典型凋亡小体和自噬体;实验组Akt mRNA表达水平的改变无统计学意义,P-Akt蛋白的表达下调并呈时间和剂量依赖性,差异有统计学意义(P<0.05或P<0.01);Caspase-8 mRNA表达水平上调,呈时间和剂量依赖性,差异有统计学意义(P<0.05或P<0.01);Caspase-9 mRNA表达水平较对照组均上调,但125μmol/L塞来昔布作用24h组mRNA表达量与对照组相比差异无统计学意义,48h和72h组与对照相比差异有统计学意义(P<0.05或P<0.01)。塞来昔布作用72h后,75μmol/L组Caspase-9 mRNA表达量与对照组相比差异无统计学意义,100μmol/L和125μmol/L组与对照相比差异有统计学意义(P<0.05或P<0.01);procaspase-8和procaspase-9蛋白被活化,表达量下调,呈时间和剂量依赖性,差异有统计学意义(P<0.05或P<0.01)。结论:1)塞来昔布可能通过PI3K/Akt通路诱导细胞凋亡和细胞自噬两种程序性死亡方式导致细胞死亡。2)塞来昔布诱导胃癌细胞凋亡的分子机制为线粒体途径和死亡受体途径。 Objective: To investigate the mechanism of celecoxib regulation on the apopt.3sis of human gastric cancer cell via the PI3K/Akt signaling pathway. Methods: After in vitro celecoxib treatment of the SGC-7901cell line, transmission electron microscopy (TEM) was used to observe the morphologic changes in cellular ultrastructure. Real-time quantitative polymerase chain reaction and Western blot analysis were used to analyze the changes in the mRNA and the protein levels of Akt, caspase-8, and caspase-9 in SGC-7901 cells after celecoxib treatment. Results: Apoptotic changes, such as nuclear envelope subsidence, chromatin margination, crescent formation of the nucleus, apoptotic bodies, and autophagosomes, were observed under TEM. Interestingly, intense autophagic vacuolization and autophagosomes were detected in the regional cytoplasm of the affected cells. There was no statistically significant change in Akt mRNA and p-Akt protein expression in the experiment group. There was a decrease in p-Akt protein expression in a time-dose dependent manner. The changes were statistically significant ( P 〈 0.05 or P 〈 0.01 ). Caspase-8 mRNA expression increased sharply in a time-dose dependent manner and the change was statistically significant ( P 〈 0.05 or P 〈 0.01 ). Caspase-9 mRNA expres- sion increased in the experimental group compared with the control; however, no statistically significant difference between the changes in caspase-9 mRNA levels in the group treated with 125 μmol/L celecoxib for 24 h and those in the control group. Significant differences were observed between the caspase-9 mRNA expression in the group treated with 125 μmol/L celecoxib for 48 and 72 h and those in the control group ( P 〈 0.05 and P 〈 0.01 ). At 72 h after celecoxib treatment, no statistically significant difference in caspase-9 mRNA expression was observed between the group treated with 75 μmol/L and the control group. Significant differences were found between the caspase-9 mRNA expression in the groups treated with 100μmol/L and with 125 μmol/L and those in the control ( P 〈 0.05 and P 〈 0.01 ). The procaspase-8 and procaspase-9 proteins were activated, and the protein expression decreased. The expression was affected in a time-dose dependent manner, with significant differences among the groups ( P 〈 0.05 or P 〈 0.01 ). Conclusion: 1) Celecoxib may result in cell death via two mechanisms, namely, apoptosis and autophagic cell death induced through the PI3K/Akt signaling pathway. 2) The mechanisms by which celecoxib induces apoptosis are the death-receptor pathway and the mitochondrial pathways.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2011年第15期882-885,共4页 Chinese Journal of Clinical Oncology
基金 国家自然科学基金(编号:30872478) 甘肃省技术研究与开发专项计划基金(编号:0912TCYA027)资助~~
关键词 塞来昔布 胃癌细胞 凋亡 自噬 PI3K/AKT通路 Celecoxib Gastric cancer Apoptosis Autophagy PI3K/Akt pathway
作者简介 通信作者:周永宁yongningzhou@sina.com
  • 相关文献

参考文献13

  • 1冉俊涛,周永宁,唐承薇,陆建荣,吴静,路红,杨国栋.塞来昔布诱导人胃癌细胞凋亡抑制新生血管形成[J].中华肿瘤杂志,2008,30(6):448-451. 被引量:10
  • 2Kim N, Kim CH, Ahn DW, et al. Anti-gastric cancer effects of celecoxib, a selective COX-2 inhibitor, through inhibitation of Akt signaling[l].J Gastroenterol Hepatol, 2009, 24(3): 480-487.
  • 3Pang RP, Zhou JG, Zeng ZR,et al. Celecoxib induces apoptosis in COX-2 deficient human gastric cancer cells through Akt/GSK3b/ NAG-1 pathway[]]. Cancer Lett, 2007, 251(2): 268-277.
  • 4Saukkonen K, RintahakaJ, Sivula A, et al. Cyclooxygenase-2 and gastric carcinogenesis[J]. APMIS, 2003, 111 (10) : 915-925.
  • 5Wang L, Chen W, Xie X, et al. Celecoxib inhibits tumor growth and angiogenesis in an orthotopic implantation tumor model of human colon cancer[J]. Exp Oncol, 2008, 30(1): 42-51.
  • 6Liu B, Shi ZL, FengJ, et al. Celecoxib, a cyclooxygenase-2 inhibitor, induces apoptosis in human osteosarcoma cell line MG-63 via down-regulation of PI3K/Akt[J].Cell Biol Int, 2008, 32(5): 494-501.
  • 7Fresno Vara JA, Casado E, de Castro J, et al. PI3K/Akt signaling pathway and cancer[J].Cancer Treat Rev, 2004, 30(2): 193-204.
  • 8谢松强,吴英良,刘广超,程鹏飞,王敏伟,马远方,赵瑾,王超杰.新型多胺缀合物NNAMB诱导K562细胞凋亡及其机制[J].中华肿瘤杂志,2008,30(7):490-493. 被引量:2
  • 9陆春伟,佟海侠,张继红,张锦华.TRAIL诱导神经母细胞瘤细胞凋亡中Caspase 8活性的变化[J].中国肿瘤临床,2007,34(14):781-784. 被引量:1
  • 10Wang N, Feng Y, Zhu M, et al. Berberine induces autophagic cell death and mitochondrial apoptosis in liver cancer cells: the cellular mechanism[J].J Cell Biochem, 2010, 111(6): 1426-1436.

二级参考文献32

共引文献10

同被引文献19

  • 1Thanaketpaisarn O,Waiwut P,Sakurai H. Artesunate enhances TRAIL-induced apoptosis in human cervical carcinoma cells through inhibition of the NF-κB and PI3K/Akt signaling pathways[J].International Journal of Oncology,2011,(01):279-285.
  • 2Xu L,Qu X,Zhang Y. Oxaliplatin enhances TRAIL-induced apoptosis in gastric cancer cells by CBL-regulated death receptor redistribution in lipid rafts[J].FEBS Letters,2009,(05):943-948.
  • 3Opel D,Westhoff MA,Bender A,et at. Phosphatidylinositol 3-kinase inhibition broadly sensitizes glioblastoma cells to death receptor-and drug-induced apoptosis[J].Cancer Research,2008,(15):6271-6280.
  • 4Shigeno M,Nakao K,Ichikawa T. Interferon-alpha sensitizes human hepatoma cells to TRAIL-induced apoptosis through DR5 upregulation and NF-kappaB inactivation[J].Oncogene,2003,(11):1653-1662.
  • 5Cunningham D,Starling N,Rao S. Capecitabine and oxaliplatia for advanced esophagogastric cancer[J].New England Journal of Medicine,2008,(01):36-46.
  • 6Shenoy K,Wu Y,Pervaiz S. LY303511 enhances TRAIL sensitivity of SHEP-1 neuroblastona cells via hydrogen peroxide-mediated mitogen-activated protein kinase activation and up-regulation of death receptors[J].Cancer Research,2009,(05):1941-1950.
  • 7Drosopoulos KG,Roberts ML,Cermak L. Transformation by oncogenie RAS sensitizes human colon cells to TRAIL-indluced apoptosis by up-regulating death receptor 4 and death receptor 5 through a MEK-dependent pathway[J].Journal of Biological Chemistry,2005,(24):22856-22867.
  • 8Park KR,Nam D,Yun HM. β-Caryophyllene oxide inhibits growth and induces apoptosis through the suppression of PI3K/Akt/mTOR/S6K1 pathways and ROS-mediated MAPKs activation[J].Cancer Letters,2011,(02):178-188.
  • 9Zauli G,Sancilio S,Cataldi A. PI-3K/Akt and NFkappaB/IkappaBalpha pathways are activated in Jurkat T cells in response to TRAIL treatment[J].Journal of Cellular Physiology,2005,(03):900-911.
  • 10Chen KF,Yeh PY,Hsu C. Bortezomib overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells in part through the inhibition of the phosphatidylinositol 3-kinase/Akt pathway[J].Journal of Biological Chemistry,2009,(17):11121-11133.

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部